ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Waxman Subcommittee Hears Support For Cancer Act Renewal

March 7, 1980

NCI says SELECT study is close to full enrollment.

April 23, 2004

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Wynder, Weinburg Head Recipients Of Milken Awards

December 14, 1990

Funding opportunities listed.

October 8, 2004

ACS Community Demonstration Projects Complete, Reach Target Populations, Teach Many Lessons

June 25, 1993